TPST icon

Tempest Therapeutics
TPST

Overview Fund Activity

38 hedge funds and large institutions have $90.7M invested in Tempest Therapeutics in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 8 closing their positions.

Holders
38
Holders Change
+8
Holders Change %
+26.67%
% of All Funds
0.83%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
16
Increased
12
Reduced
4
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
1
BlackRock
New York
$5.41M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$3.83M
3
State Street
3
State Street
Massachusetts
$1.35M
4
IBT
4
International Biotechnology Trust
United Kingdom
$2.06M
5
Renaissance Technologies
5
Renaissance Technologies
New York
$2.41M

Top Sellers

1
PM
1
Prosight Management
Texas
$854K
2
Millennium Management
2
Millennium Management
New York
$0
3
ASP
3
Adams Street Partners
Illinois
$4.73M
4
TEE
4
Tibra Equities Europe
United Kingdom
$0
5
WVP
5
Worth Venture Partners
New Jersey
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Federated Hermes
51
Federated Hermes
Pennsylvania
– -$2K -1 Closed
1 2
3